- Business Wire•10 minutes ago
The Merck Foundation and YMCA of the USA announced today that the Merck Foundation has provided a grant of $2 million over three years to support efforts to expand the YMCA’s Diabetes Prevention Program .
- Business Wire•yesterdayMSD Animal Health Demonstrates Commitment to Eliminate Rabies Worldwide with Donation of More Than Two Million Doses of Vaccine to Date
MSD Animal Health is proud to announce a landmark accomplishment in its fight against rabies with the donation of now more than two million doses of its NOBIVAC® rabies vaccine to organizations working to eliminate this completely preventable disease.
- Business Wire•yesterdayTwo New Trials of Merck’s KEYTRUDA® (pembrolizumab) as Monotherapy and in Combination with Chemotherapy for First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer to be Presented During Presidential Session at ESMO 2016
Merck , known as MSD outside the United States and Canada, today announced that extensive data on KEYTRUDA® , the company’s anti-PD-1 therapy, have been accepted for presentation at the European Society for Medical Oncology 2016 Congress in Copenhagen, Denmark, Oct.
Merck & Co., Inc. (MRK)
NYSE - NYSE Real Time Price. Currency in USD
|Day's Range||62.49 - 63.48|
|52wk Range||47.97 - 64.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||34.72|
|Avg Vol (3m)||9,602,160|
|Dividend & Yield||1.84 (2.94%)|